And together with that, the FDA is adopting to precision medicine, adding new ways of testing drugs: http://www.xconomy.com/national/2017/05/30/woodcock-new-ap

And together with that, the FDA is adopting to precision medicine, adding new ways of testing drugs: http://www.xconomy.com/national/2017/05/30/woodcock-new-approvals-show-fda-is-adapting-to-precision-medicine/# http://www.xconomy.com/national/2017/05/30/woodcock-new-appr... Which could open new paths, not only in cancer but other types of diseases.